| 1 | Neuroectodermal Tumors | 35.3% |
| 2 | Follicular cyst | 33.3% |
| 3 | Mucocele | 33.3% |
| 4 | Pilonidal Cyst | 33.3% |
| 5 | Thyroglossal Cyst | 33.3% |
| 6 | Synovial Cyst | 33.3% |
| 7 | Chordoma | 30.3% |
| 8 | Germinoma | 30.3% |
| 9 | Teratocarcinoma | 30.3% |
| 10 | Neoplasms, Neuroepithelial | 29.8% |
| 11 | Gliomatosis cerebri | 29.8% |
| 12 | Trophoblastic Neoplasms | 27.2% |
| 13 | leukemia | 26.4% |
| 14 | Neoplasms, Glandular and Epithelial | 26.4% |
| 15 | melanoma | 25.7% |
| 16 | Hamartoma | 25.3% |
| 17 | Neoplasms, Hormone-Dependent | 25.3% |
| 18 | Neoplasms, Multiple Primary | 25.3% |
| 19 | Paraneoplastic Syndromes | 25.3% |
| 20 | Precancerous Conditions | 25.3% |
| 21 | Neoplasms, Second Primary | 25.3% |
| 22 | Lymphocele | 25.2% |
| 23 | Pancreatic Cyst | 25.2% |
| 24 | Craniopharyngioma | 24.8% |
| 25 | Neuroectodermal Tumor, Melanotic | 24.8% |
| 26 | Neuroendocrine Tumors | 24.8% |
| 27 | Breast Cyst | 24.8% |
| 28 | Mediastinal Cyst | 24.8% |
| 29 | Parovarian Cyst | 24.8% |
| 30 | Pericardial Cyst | 24.8% |
| 31 | Thymic Cyst | 24.8% |
| 32 | Myxoid cyst | 24.8% |
| 33 | Medulloblastoma | 24.1% |
| 34 | Adenoma, Acidophil | 22.9% |
| 35 | Ganglioneuroma | 22.9% |
| 36 | Glioma | 22.9% |
| 37 | Malignant Glioma | 22.9% |
| 38 | Carcinoma 256, Walker | 22.1% |
| 39 | Carcinosarcoma | 21.7% |
| 40 | Hemangiosarcoma | 21.7% |
| 41 | lymphangiosarcoma | 21.7% |
| 42 | Carcinoid Tumor | 21.5% |
| 43 | Neurilemmoma | 21.5% |
| 44 | Melanoma, Experimental | 21.2% |
| 45 | Dysgerminoma | 21.1% |
| 46 | Seminoma | 21.1% |
| 47 | Hutchinson's Melanotic Freckle | 20.8% |
| 48 | Melanoma, Amelanotic | 20.8% |
| 49 | Carcinoma, Ehrlich Tumor | 20.3% |
| 50 | Carcinoma, Lewis Lung | 20.3% |
| 51 | Choriocarcinoma | 20.3% |
| 52 | Meningioma | 19.8% |
| 53 | Paraganglioma | 19.7% |
| 54 | Histiocytic Disorders, Malignant | 19.7% |
| 55 | Corpus Luteum Cyst | 19.5% |
| 56 | Ovarian Cysts | 19.5% |
| 57 | Astrocytoma | 19.5% |
| 58 | Ependymoma | 19.5% |
| 59 | oligodendroglioma | 19.5% |
| 60 | Ganglioglioma | 19.5% |
| 61 | gliosarcoma | 19.5% |
| 62 | Anaplastic astrocytoma | 19.5% |
| 63 | Anaplastic Oligodendroglioma | 19.5% |
| 64 | Leukemia, Experimental | 18.9% |
| 65 | Neoplastic Processes | 18.9% |
| 66 | Neoplastic Syndromes, Hereditary | 18.9% |
| 67 | Pregnancy Complications, Neoplastic | 18.9% |
| 68 | Malignant Carcinoid Syndrome | 18.8% |
| 69 | Neoplasms, Experimental | 18.6% |
| 70 | Basal cell carcinoma | 18.2% |
| 71 | Carcinoma, Papillary | 18.2% |
| 72 | Squamous cell carcinoma | 18.2% |
| 73 | Chondrosarcoma | 18.2% |
| 74 | Cystadenoma | 18.2% |
| 75 | leiomyosarcoma | 18.2% |
| 76 | liposarcoma | 18.2% |
| 77 | Mesothelioma | 18.2% |
| 78 | synovial sarcoma | 18.2% |
| 79 | Angiomyolipoma | 18.2% |
| 80 | Clear Cell Sarcoma of Soft Tissue | 18.2% |
| 81 | Alveolar Soft Part Sarcoma | 18.2% |
| 82 | Sarcoma, Myeloid | 18.2% |
| 83 | Carcinoma, Basal Cell | 18.2% |
| 84 | Glioblastoma | 17.8% |
| 85 | Neuroblastoma | 17.8% |
| 86 | Glioblastoma Multiforme | 17.8% |
| 87 | Pancreatic Pseudocyst | 17.6% |
| 88 | Multiple Endocrine Neoplasia | 17.2% |
| 89 | Leukemia, Plasma Cell | 17.2% |
| 90 | Pheochromocytoma | 17.1% |
| 91 | Ganglioneuroblastoma | 17% |
| 92 | Adenoma | 16.9% |
| 93 | Ameloblastoma | 16.9% |
| 94 | Angiokeratoma | 16.9% |
| 95 | Carcinoma | 16.9% |
| 96 | Hemangioma | 16.9% |
| 97 | hemangiopericytoma | 16.9% |
| 98 | Lymphangioma | 16.9% |
| 99 | Mesenchymoma | 16.9% |
| 100 | Nevus | 16.9% |
| 101 | Hepatoblastoma | 16.9% |
| 102 | Mixed Tumor, Mullerian | 16.9% |
| 103 | Angiofibroma | 16.9% |
| 104 | Sarcoma | 16.9% |
| 105 | Epithelioma | 16.9% |
| 106 | Leukemia L1210 | 16.7% |
| 107 | Leukemia P388 | 16.7% |
| 108 | Acanthoma | 16.7% |
| 109 | Composite Lymphoma | 16.6% |
| 110 | Choledochal Cyst | 16.6% |
| 111 | Cystadenocarcinoma | 16.5% |
| 112 | Fibrosarcoma | 16.5% |
| 113 | Osteosarcoma | 16.5% |
| 114 | Mucoepidermoid Carcinoma | 16.5% |
| 115 | Sarcoma, Experimental | 16.1% |
| 116 | Leukemia, Radiation-Induced | 15.9% |
| 117 | Carcinoma, Lobular | 15.9% |
| 118 | Lymphoma | 15.6% |
| 119 | Adenofibroma | 15.6% |
| 120 | Fibroadenoma | 15.6% |
| 121 | Malignant Fibrous Histiocytoma | 15.6% |
| 122 | Retinoblastoma | 15.4% |
| 123 | Paraneoplastic Encephalomyelitis | 15.2% |
| 124 | Abdominal Neoplasms | 14.9% |
| 125 | Erythroplasia | 14.9% |
| 126 | Head and Neck Neoplasms | 14.9% |
| 127 | Soft Tissue Neoplasms | 14.9% |
| 128 | Thoracic Neoplasms | 14.9% |
| 129 | Aberrant Crypt Foci | 14.9% |
| 130 | Sarcoma 180 | 14.9% |
| 131 | Mammary Neoplasms, Experimental | 14.9% |
| 132 | Neoplasms, Radiation-Induced | 14.8% |
| 133 | Carcinoid Heart Disease | 14.8% |
| 134 | Bowen's Disease | 14.8% |
| 135 | Rhabdomyosarcoma | 14.8% |
| 136 | Giant Cell Tumor of Bone | 14.8% |
| 137 | Thymoma | 14.7% |
| 138 | Hydatidiform Mole | 14.4% |
| 139 | Dermatofibrosarcoma | 13.9% |
| 140 | Dermatofibrosarcoma Protuberans | 13.9% |
| 141 | Polycystic Ovary Syndrome | 13.8% |
| 142 | Basal Cell Nevus Syndrome | 13.8% |
| 143 | Alveolar rhabdomyosarcoma | 13.1% |
| 144 | Endometrial Stromal Sarcoma | 13% |
| 145 | Plasmacytoma | 12.6% |
| 146 | Acoustic Neuroma | 12.5% |
| 147 | Malignant histiocytosis | 12.5% |
| 148 | Histiocytic sarcoma | 12.5% |
| 149 | Adenocarcinoma | 12.2% |
| 150 | Carcinoma in Situ | 12.2% |
| 151 | Carcinoma, Transitional Cell | 12.2% |
| 152 | Phyllodes Tumor | 12.2% |
| 153 | Hemangioendothelioma | 12.2% |
| 154 | Lipoma | 12.2% |
| 155 | Myoma | 12.2% |
| 156 | Myxoma | 12.2% |
| 157 | Neuroma | 12.2% |
| 158 | Papilloma | 12.2% |
| 159 | Pseudomyxoma Peritonei | 12.2% |
| 160 | Papillomatosis | 12.2% |
| 161 | Angiolipoma | 12.2% |
| 162 | Myelolipoma | 12.2% |
| 163 | Neoplasms, Bone Tissue | 12.2% |
| 164 | Neoplasms, Fibrous Tissue | 12.2% |
| 165 | Smooth Muscle Tumor | 12.2% |
| 166 | Adenomatosis, Pulmonary | 12.2% |
| 167 | Adenomatous Polyps | 12.2% |
| 168 | Carcinoma, Large Cell | 12.2% |
| 169 | Carcinoma, Small Cell | 12.2% |
| 170 | Desmoplastic Small Round Cell Tumor | 12.2% |
| 171 | Chondroma | 12.2% |
| 172 | Enchondroma | 12.2% |
| 173 | Lymphomatoid Granulomatosis | 12.1% |
| 174 | Tuberous Sclerosis | 12.1% |
| 175 | Lymphangioleiomyomatosis | 12% |
| 176 | Neurofibrosarcoma | 12% |
| 177 | Vipoma | 11.8% |
| 178 | Multiple Endocrine Neoplasia Type 1 | 11.8% |
| 179 | Digestive System Neoplasms | 11.7% |
| 180 | Endocrine Gland Neoplasms | 11.7% |
| 181 | Eye Neoplasms | 11.7% |
| 182 | Nervous System Neoplasms | 11.7% |
| 183 | Bone neoplasms | 11.3% |
| 184 | Leukoplakia | 11.3% |
| 185 | Skin Neoplasms | 11.3% |
| 186 | Hematologic Neoplasms | 11.3% |
| 187 | Carcinoma, Pancreatic Ductal | 11.3% |
| 188 | Nephroblastoma | 11.2% |
| 189 | Optic Nerve Glioma | 11.2% |
| 190 | Barrett Esophagus | 11.1% |
| 191 | Actinic keratosis | 11.1% |
| 192 | Neoplasm Invasiveness | 11.1% |
| 193 | Neoplasm Metastasis | 11.1% |
| 194 | Neoplasm Recurrence, Local | 11.1% |
| 195 | Splenic Neoplasms | 11.1% |
| 196 | Carcinogenesis | 11.1% |
| 197 | Metastasis | 11.1% |
| 198 | Parathyroid Neoplasms | 10.3% |
| 199 | Peritoneal Neoplasms | 10.3% |
| 200 | Thyroid Neoplasm | 10.3% |
| 201 | Thyroid carcinoma | 10.3% |
| 202 | Retroperitoneal Neoplasms | 10.1% |
| 203 | Adenoid Cystic Carcinoma | 9.9% |
| 204 | fibroma | 9.9% |
| 205 | Fibromatosis | 9.9% |
| 206 | Osteoblastoma | 9.9% |
| 207 | Osteoma | 9.9% |
| 208 | Rhabdomyoma | 9.9% |
| 209 | Chondromatosis | 9.9% |
| 210 | Hepatocellular Adenoma | 9.9% |
| 211 | Adenocarcinoma, Clear Cell | 9.9% |
| 212 | Cholangiocarcinoma | 9.9% |
| 213 | Cervical Intraepithelial Neoplasia | 9.9% |
| 214 | Hemangioblastoma | 9.9% |
| 215 | Lymphoma, Extranodal NK-T-Cell | 9.9% |
| 216 | Hodgkin Disease | 9.9% |
| 217 | Lymphoma, Non-Hodgkin | 9.9% |
| 218 | Liver Neoplasms, Experimental | 9.6% |
| 219 | Neoplasms, Germ Cell and Embryonal | 9.2% |
| 220 | Germ Cell Cancer | 9.2% |
| 221 | Leukemia, Myelomonocytic, Chronic | 9.1% |
| 222 | Tracheal Neoplasms | 9.1% |
| 223 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 9.1% |
| 224 | Leukoplakia, Oral | 8.9% |
| 225 | Pancreatic Neoplasm | 8.9% |
| 226 | Paraneoplastic Cerebellar Degeneration | 8.8% |
| 227 | Fibromatosis, Aggressive | 8.8% |
| 228 | Fibromatosis, Abdominal | 8.8% |
| 229 | Klatskin Tumor | 8.8% |
| 230 | Mesoblastic Nephroma | 8.6% |
| 231 | insulinoma | 8.5% |
| 232 | Dermoid Cyst | 8.5% |
| 233 | Prolactinoma | 8.5% |
| 234 | Growth Hormone-Secreting Pituitary Adenoma | 8.5% |
| 235 | Primary amyloidosis | 8.3% |
| 236 | Adenomatous Polyposis Coli | 8.2% |
| 237 | Cyst | 8.1% |
| 238 | Gastrinoma | 8.1% |
| 239 | Glucagonoma | 8.1% |
| 240 | Thyroid Nodule | 7.7% |
| 241 | Mouth Neoplasms | 7.7% |
| 242 | Central Nervous System Neoplasms | 7.7% |
| 243 | Vascular Neoplasms | 7.7% |
| 244 | Thymus Neoplasms | 7.7% |
| 245 | Esophageal Neoplasms | 7.6% |
| 246 | Genital Neoplasms, Female | 7.6% |
| 247 | Limbic Encephalitis | 7.5% |
| 248 | Lymphatic Metastasis | 7.5% |
| 249 | Neoplasms, Unknown Primary | 7.5% |
| 250 | Leukemic Infiltration | 7.5% |
| 251 | Breast Neoplasms, Male | 7.5% |
| 252 | Neoplasm Micrometastasis | 7.5% |
| 253 | Triple Negative Breast Neoplasms | 7.5% |
| 254 | Mastocytoma | 7.5% |
| 255 | Mastocytosis | 7.4% |
| 256 | Sturge-Weber Syndrome | 7.4% |
| 257 | Mastocytosis, Systemic | 7.4% |
| 258 | Leukemia, Myeloid, Chronic-Phase | 7.4% |
| 259 | Leydig Cell Tumor | 7.3% |
| 260 | granulosa cell tumor | 7.3% |
| 261 | Carcinoma, Ovarian Epithelial | 7.3% |
| 262 | Gastrointestinal Stromal Tumors | 7.3% |
| 263 | Hemangioma, Cavernous | 7.3% |
| 264 | Leukemia, T-Cell | 7.2% |
| 265 | Leukemia, B-Cell | 7.2% |
| 266 | Peutz-Jeghers Syndrome | 7.2% |
| 267 | neurofibroma | 7.2% |
| 268 | Lymphoma, Follicular | 7.2% |
| 269 | T-Cell Lymphoma | 7.2% |
| 270 | Mantle cell lymphoma | 7.2% |
| 271 | Adrenocortical carcinoma | 7% |
| 272 | Teratoma | 6.7% |
| 273 | Lambert-Eaton Myasthenic Syndrome | 6.7% |
| 274 | Testicular Neoplasms | 6.7% |
| 275 | Radicular Cyst | 6.5% |
| 276 | Waldenstrom Macroglobulinemia | 6.2% |
| 277 | Multiple Myeloma | 6.2% |
| 278 | Adrenal Gland Neoplasms | 6.2% |
| 279 | Gastrointestinal Neoplasms | 6.2% |
| 280 | Genital Neoplasms, Male | 6.2% |
| 281 | Liver neoplasms | 6.2% |
| 282 | Uveal Neoplasms | 6.2% |
| 283 | Urologic Neoplasms | 6.1% |
| 284 | Renal Cell Carcinoma | 6.1% |
| 285 | Papillary Renal Cell Carcinoma | 6.1% |
| 286 | Sebaceous Gland Neoplasms | 6% |
| 287 | Spinal Neoplasms | 6% |
| 288 | Bone Marrow Neoplasms | 6% |
| 289 | Nasopharyngeal carcinoma | 6% |
| 290 | Opsoclonus-Myoclonus Syndrome | 5.9% |
| 291 | Denys-Drash Syndrome | 5.9% |
| 292 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5.9% |
| 293 | Leukemia, Large Granular Lymphocytic | 5.9% |
| 294 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.9% |
| 295 | Lymphoma, T-Cell, Cutaneous | 5.8% |
| 296 | Lymphoma, AIDS-Related | 5.8% |
| 297 | Enteropathy-Associated T-Cell Lymphoma | 5.8% |
| 298 | Primary Effusion Lymphoma | 5.8% |
| 299 | Carcinoma, Endometrioid | 5.8% |
| 300 | Meningeal Neoplasms | 5.8% |
| 301 | Dupuytren Contracture | 5.4% |
| 302 | Palatal Neoplasms | 5.3% |
| 303 | Nose Neoplasms | 5.3% |
| 304 | Myelitis, Transverse | 5.3% |
| 305 | Urticaria Pigmentosa | 5.3% |
| 306 | Mycosis Fungoides | 5.2% |
| 307 | Lymphomatoid Papulosis | 5.2% |
| 308 | Plasmablastic lymphoma | 5.2% |
| 309 | Meningeal Carcinomatosis | 4.9% |
| 310 | Ear Neoplasms | 4.8% |
| 311 | Eyelid Neoplasms | 4.8% |
| 312 | Lung Neoplasms | 4.8% |
| 313 | Pleural Neoplasms | 4.8% |
| 314 | Pituitary Adenoma | 4.7% |
| 315 | Pituitary Neoplasms | 4.7% |
| 316 | Cell Transformation, Viral | 4.7% |
| 317 | Brain Neoplasms | 4.7% |
| 318 | Salivary Gland Neoplasms | 4.7% |
| 319 | Spinal Cord Neoplasms | 4.7% |
| 320 | Tongue Neoplasms | 4.7% |
| 321 | Uterine Neoplasms | 4.6% |
| 322 | Vaginal Neoplasms | 4.6% |
| 323 | Vulvar Neoplasms | 4.6% |
| 324 | Uterine Cancer | 4.6% |
| 325 | Fallopian Tube Neoplasms | 4.6% |
| 326 | Xeroderma Pigmentosum | 4.4% |
| 327 | ovarian neoplasm | 4.3% |
| 328 | Burkitt Lymphoma | 4.2% |
| 329 | Bronchial Neoplasms | 4% |
| 330 | Pharyngeal Neoplasms | 4% |
| 331 | Multiple Pulmonary Nodules | 4% |
| 332 | Supratentorial Neoplasms | 3.9% |
| 333 | Central Nervous System Cysts | 3.9% |
| 334 | Endometrial Neoplasms | 3.9% |
| 335 | Bile Duct Neoplasms | 3.9% |
| 336 | gallbladder neoplasm | 3.9% |
| 337 | Intestinal Neoplasms | 3.9% |
| 338 | Penile Neoplasms | 3.9% |
| 339 | Prostatic Neoplasms | 3.9% |
| 340 | Stomach Neoplasms | 3.9% |
| 341 | Polycythemia Vera | 3.8% |
| 342 | Sezary Syndrome | 3.7% |
| 343 | Brain Stem Neoplasms | 3.6% |
| 344 | Laryngeal neoplasm | 3.5% |
| 345 | Choroid Plexus Papilloma | 3.4% |
| 346 | Hypopharyngeal Neoplasms | 3.3% |
| 347 | Pleural Effusion, Malignant | 3.3% |
| 348 | Hypopharyngeal Cancer | 3.3% |
| 349 | Zollinger-Ellison syndrome | 3.3% |
| 350 | Bladder Neoplasm | 3.3% |
| 351 | Kidney Neoplasm | 3.3% |
| 352 | Ureteral Neoplasms | 3.3% |
| 353 | Urethral Neoplasms | 3.3% |
| 354 | Parotid Neoplasms | 3.3% |
| 355 | Prostatic Neoplasms, Castration-Resistant | 3.3% |
| 356 | Nelson Syndrome | 3.3% |
| 357 | Tonsillar Neoplasms | 3% |
| 358 | Cerebellar Neoplasms | 3% |
| 359 | Cecal Neoplasms | 2.8% |
| 360 | Duodenal Neoplasms | 2.8% |
| 361 | Appendiceal Neoplasms | 2.5% |
| 362 | Colonic Neoplasms | 2.5% |
| 363 | Rectal Neoplasms | 2.5% |
| 364 | Nasopharyngeal Neoplasms | 2.5% |
| 365 | Colorectal Neoplasms | 2.4% |
| 366 | Paranasal Sinus Neoplasms | 2.2% |
| 367 | Anus Neoplasms | 2.1% |
| 368 | Sigmoid Neoplasms | 2.1% |
| 369 | Maxillary Sinus Neoplasms | 2% |